Unlocking the Potential of IFI44: A Promising Drug Target and Biomarker

Target Name: IFI44

NCBI ID: G10561

IFI44

Unlocking the Potential of IFI44: A Promising Drug Target and Biomarker

Issuing from the endoplasmic reticulum, IFI44 (Microtubule-associated protein 44) is a protein that plays a critical role in the transport and organization of various cellular processes. Its localization to the microtubules, which are dynamic structures composed of interconnected filaments, is a testament to its functionality in regulating the mechanical properties of cells. The identification of IFI44 as a potential drug target and biomarker has significant implications for the development of new therapeutics and diagnostic tools.

Structure and Function

The IFI44 protein is a 21-kDa protein that belongs to the IFI44 family, which is characterized by the presence of a unique C-terminal hypervariable region (HVR). This HVR is important for IFI44's stability and can interact with various cellular components, including microtubules and actin filaments.

The IFI44 protein functions as a key regulator of microtubule dynamics and stability, ensuring the proper assembly and disassembly of microtubules in response to various cellular stimuli. In the cytosol, IFI44 interacts with the microtubules and is involved in the regulation of microtubule dynamics, as well as the maintenance of microtubule stability. This is achieved by its ability to interact with the microtubules and to modulate the activity of microtubule-associated proteins (MAPs), which in turn regulate microtubule dynamics and stability.

In addition to its role in regulating microtubule dynamics, IFI44 has also been shown to play a crucial role in the regulation of cellular signaling pathways. Its localization to the endoplasmic reticulum, where it interacts with various cellular components, including but not limited to microtubules, actin filaments, and various signaling proteins, suggests that IFI44 may be involved in the regulation of various cellular processes, including cell signaling, cell division, and cellular growth.

Chemical Characterization and Therapeutic Potential

The chemical characterization of IFI44 has provided valuable insights into its molecular mechanisms of action and potential therapeutic potential. One of the most significant findings is the IFI44's ability to interact with various cellular components, including microtubules and actin filaments. This interaction suggests that IFI44 may be a useful drug target to modulate the mechanical properties of cells, which could have implications for the development of new therapeutic strategies for various diseases.

In addition to its potential therapeutic applications, IFI44 has also been identified as a potential biomarker for various diseases. Its localization to the endoplasmic reticulum, where it interacts with various cellular components, suggests that IFI44 may be involved in the regulation of various cellular processes, including cell signaling, cell division, and cellular growth. This suggests that IFI44 may be a useful biomarker for the diagnosis and monitoring of various diseases, including but not limited to cancer, neurodegenerative diseases, and developmental disorders.

Conclusion

In conclusion, the identification of IFI44 as a potential drug target and biomarker has significant implications for the development of new therapeutic strategies for various diseases. Its ability to interact with various cellular components, including microtubules and actin filaments, suggests that IFI44 may be a useful target for the regulation of cellular mechanics and signaling pathways. Further research is needed to fully understand IFI44's molecular mechanisms of action and potential therapeutic applications.

Protein Name: Interferon Induced Protein 44

Functions: This protein aggregates to form microtubular structures

The "IFI44 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about IFI44 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets